DOI: 10.1055/s-00023610

Drug Research

References

Davies M, Osborne V, Lane S. et al.
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.

Drug Saf 2020;
43: 645-656

Download Bibliographical Data

Access:
Access: